- Home
- PYPD vs SELF Comparison
PYPD vs SELF Comparison
Compare PYPD & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- SELF
- Stock Information
- Founded
- PYPD 2008
- SELF 1983
- Country
- PYPD Israel
- SELF United States
- Employees
- PYPD N/A
- SELF N/A
- Industry
- PYPD Medical/Dental Instruments
- SELF Real Estate Investment Trusts
- Sector
- PYPD Health Care
- SELF Real Estate
- Exchange
- PYPD Nasdaq
- SELF Nasdaq
- Market Cap
- PYPD 54.7M
- SELF 56.7M
- IPO Year
- PYPD 2020
- SELF N/A
- Fundamental
- Price
- PYPD $3.80
- SELF $4.94
- Analyst Decision
- PYPD Strong Buy
- SELF
- Analyst Count
- PYPD 5
- SELF 0
- Target Price
- PYPD $12.00
- SELF N/A
- AVG Volume (30 Days)
- PYPD 92.7K
- SELF 27.5K
- Earning Date
- PYPD 11-12-2025
- SELF 11-07-2025
- Dividend Yield
- PYPD N/A
- SELF 5.88%
- EPS Growth
- PYPD N/A
- SELF 9.99
- EPS
- PYPD N/A
- SELF 0.22
- Revenue
- PYPD N/A
- SELF $12,707,884.00
- Revenue This Year
- PYPD N/A
- SELF $2.50
- Revenue Next Year
- PYPD N/A
- SELF $1.46
- P/E Ratio
- PYPD N/A
- SELF $22.44
- Revenue Growth
- PYPD N/A
- SELF 4.08
- 52 Week Low
- PYPD $2.30
- SELF $4.73
- 52 Week High
- PYPD $3.93
- SELF $5.89
- Technical
- Relative Strength Index (RSI)
- PYPD 68.11
- SELF 43.31
- Support Level
- PYPD $3.10
- SELF $4.88
- Resistance Level
- PYPD $3.50
- SELF $5.05
- Average True Range (ATR)
- PYPD 0.18
- SELF 0.09
- MACD
- PYPD 0.06
- SELF 0.01
- Stochastic Oscillator
- PYPD 94.87
- SELF 64.06
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.